Literature DB >> 27411468

A Case Report of Inversa Acne and Evaluation for Mutations in the NCSTN, PSENEN, and PSEN1 Genes.

Bi-Rong Guo1, Cong-Sheng Li2, Qi-Ming Zhu1, Kang Xu1, Wei Pan1, Peng Jiang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27411468      PMCID: PMC4960970          DOI: 10.4103/0366-6999.185853

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
To the Editor: Acne inversa (AI; OMIM: 142690) is a painful chronic follicular disease, characterized by recurrent draining sinuses and abscesses with subsequent scarring and chronic seepage, predominantly in skin folds that carry terminal hairs and apocrine glands. It mainly affects the scalp, neck, the axillae, perineum, and inframammary regions. AI significantly affects patients’ quality of life because of the chronic and recurrent nature of symptoms as well as the lack of satisfying treatment options. Gao et al.[1] have already discovered that the genetic locus responsible for AI is located at chromosome 1p21.1-1q25.3 by genome-wide linkage scan, but could not identify any causal gene for the disease. Wang et al.[2] found independent loss-of-function mutations in presenilin enhancer gamma-secretase subunit (PSENEN), presenilin 1 (PSEN1), or Nicastrin (NCSTN), which encode essential components of the γ-secretase multiprotein complex. Liu et al.[3] further confirmed the pathogenic role of NCSTN mutations in AI by combining exome sequencing with previous genome-wide linkage analysis. Jiao et al.[4] found a novel mutation of c. 1258C >T in NCSTN, which would lead to a substitution of glutamine by a premature termination codon at amino acid 420 (p.Q420X). In November 2014, a 33-year-old Chinese man consulted for severe facial acne associated with suppurating lesions of major body folds, which presented with typical characteristics of AI. The patient reported that cysts appeared repeatedly on his head in August 2002, subsequently, inflammatory subcutaneous nodules developed on the face, neck, and armpit [Figure 1] (the patient with AI refused to provide the photo on his face and neck, now we offer only typical photo in his armpit). Isotretinoin soft capsules, minocycline, and cephalosporins have been administered orally, while rivanol and retinoic acid cream were used on local lesions, but the lesions were not improved obviously. No other skin, nail, or hair abnormality was found. The patient denied other family member had similar lesions and denied cousins matrimony history of his parents. After physical examination by experienced clinical dermatologists, the clinical characteristics supported the diagnosis of AI.
Figure 1

Clinical features of the patient with acne inversa. Fibrosis, nodules, abscesses, and scars on the armpit.

Clinical features of the patient with acne inversa. Fibrosis, nodules, abscesses, and scars on the armpit. Here, we reported this patient with AI and sequenced NCSTN, PSENEN, and PSEN1 genes. The study was approved by the Ethics Committee of Anhui Medical University and conducted according to the principles of the Declaration of Helsinki. The result of sequencing showed no causative mutation in the coding regions or splice sites of these three genes. AI is a chronic inflammatory skin disease that presents with nodules, cysts, and abscesses in apocrine gland-bearing sites. In this study, we examined the γ-secretase genes NCSTN, PSENEN, and PSEN1 for mutations and found no mutation. This result suggests that AI is a genetically heterogeneous disorder. The causative genes of some monogenic disorders, such as disseminated superficial actinic porokeratosis,[5] have been found by linkage analysis combined with whole exome sequencing, but we did not find the mutation of these disease-causing genes in some families or sporadic patients, indicating that there may be other causative genes. Hence, additional and as yet unknown genes predispose to the development of this distressing disorder. Further study, using extensive sequencing of noncoding or regulatory sequence of these genes, is warranted.

Financial support and sponsorship

This work was supported by a grant from the National Natural Science Foundation of China (No. 81301352).

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Gamma-secretase gene mutations in familial acne inversa.

Authors:  Baoxi Wang; Wei Yang; Wen Wen; Jing Sun; Bin Su; Bo Liu; Donglai Ma; Dan Lv; Yaran Wen; Tao Qu; Min Chen; Miao Sun; Yan Shen; Xue Zhang
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3.

Authors:  Min Gao; Pei-Guang Wang; Yong Cui; Sen Yang; Yu-Hui Zhang; Da Lin; Kai-Yue Zhang; Yan-Hua Liang; Liang-Dan Sun; Kai-Lin Yan; Feng-Li Xiao; Wei Huang; Xue-Jun Zhang
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

3.  Confirmation by exome sequencing of the pathogenic role of NCSTN mutations in acne inversa (hidradenitis suppurativa).

Authors:  Yuan Liu; Min Gao; Yong-mei Lv; Xu Yang; Yun-qing Ren; Tao Jiang; Xin Zhang; Bi-rong Guo; Min Li; Qing Zhang; Peng Zhang; Fu-sheng Zhou; Gang Chen; Xian-yong Yin; Xian-bo Zuo; Liang-dan Sun; Xiao-dong Zheng; Shu-mei Zhang; Jian-jun Liu; Youwen Zhou; Ying-rui Li; Jun Wang; Jian Wang; Huan-ming Yang; Sen Yang; Rui-qiang Li; Xue-jun Zhang
Journal:  J Invest Dermatol       Date:  2011-03-24       Impact factor: 8.551

4.  A novel nicastrin mutation in a large Chinese family with hidradenitis suppurativa.

Authors:  T Jiao; H Dong; L Jin; S Wang; J Wang
Journal:  Br J Dermatol       Date:  2013-03-21       Impact factor: 9.302

5.  Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.

Authors:  Sheng-Quan Zhang; Tao Jiang; Min Li; Xin Zhang; Yun-Qing Ren; Sheng-Cai Wei; Liang-Dan Sun; Hui Cheng; Yang Li; Xian-Yong Yin; Zheng-Mao Hu; Zhen-Ying Wang; Yuan Liu; Bi-Rong Guo; Hua-Yang Tang; Xian-Fa Tang; Yan-Tao Ding; Jian-Bo Wang; Ping Li; Bao-Yu Wu; Wen Wang; Xiang-Feng Yuan; Jun-Sheng Hou; Wei-Wei Ha; Wen-Ju Wang; Yu-Juan Zhai; Jing Wang; Fang-Fang Qian; Fu-Sheng Zhou; Gang Chen; Xian-Bo Zuo; Xiao-Dong Zheng; Yu-Jun Sheng; Jin-Ping Gao; Bo Liang; Pan Li; Jun Zhu; Feng-Li Xiao; Pei-Guang Wang; Yong Cui; Hui Li; Sheng-Xiu Liu; Min Gao; Xing Fan; Song-Ke Shen; Ming Zeng; Guang-Qing Sun; Yu Xu; Jing-Chu Hu; Ting-Ting He; Ying-Rui Li; Huan-Ming Yang; Jian Wang; Zhong-Yi Yu; Hui-Feng Zhang; Xin Hu; Ke Yang; Jie Wang; Shi-Xiang Zhao; You-Wen Zhou; Jian-Jun Liu; Wei-Dong Du; Li Zhang; Kun Xia; Sen Yang; Jun Wang; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2012-09-16       Impact factor: 38.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.